Position in REGN
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$11,602,734
-$703,189 QoQ
Shares Held
15,017
-5.8% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 86.65423548215237.ToString("F0")%
Shared 0.ToString("F0")%
None 13.34576451784763.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Ethic Inc. holds $32,626,777 across 32 Biotechnology names. REGN ranks #1 (35.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
15,017 | $11,602,734 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
17,896 | $7,991,279 | |
| 3 | ARGX |
Argenx SE
|
4,029 | $2,942,177 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,869 | $1,280,136 | |
| 5 | CYTK |
Cytokinetics Inc
|
18,998 | $1,252,158 | |
| 6 | INSM |
INSMED Inc
|
6,670 | $1,090,678 | |
| 7 | MRNA |
Moderna, Inc.
|
13,576 | $689,660 | |
| 8 | PRAX |
Praxis Precision Medicines, Inc.
|
1,990 | $641,158 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,602,734 | 15,017 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $12,305,923 | 15,943 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $9,273,519 | 16,493 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $8,844,675 | 16,847 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $4,490,982 | 7,081 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $7,599,136 | 10,668 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,474,587 | 6,159 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $6,771,786 | 6,443 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $5,927,975 | 6,159 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $4,880,657 | 5,557 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,787,981 | 5,818 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,053,284 | 5,641 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,585,740 | 5,581 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,388,131 | 3,310 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,676,709 | 2,434 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,460,682 | 2,471 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $1,347,252 | 1,929 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $963,068 | 1,525 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $843,015 | 1,393 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $579,764 | 1,038 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $353,908 | 748 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $418,856 | 867 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $460,139 | 822 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $374,813 | 601 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $229,984 | 471 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||